Ab­b­Vie inks deal with Parvus; Sofinno­va in­vests in Cure51

Plus, news about Aque­s­tive Ther­a­peu­tics and Cy­bin:

Ab­b­Vie en­lists Parvus Ther­a­peu­tics for IBD pact: Ab­b­Vie will have the op­tion to de­vel­op and com­mer­cial­ize Parvus’ ther­a­pies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER